As clinical trials become more complex and decentralized, the role of the CRA is evolving from site monitor to strategic, digitally fluent partner, requiring expertise in hybrid oversight, risk-based monitoring, and multi-system data management.
Helen Yeardley
Advertisement
Senior Vice President, Global Clinical Operations, ICON plc
Articles by Helen Yeardley
Adjusting to the changing dynamics of the clinical research associate role.
Advertisement
Latest Updated Articles
The CRA of the Future: From ‘Road Warrior’ to Site ‘Owner’February 13th 2024
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
Building AI Assistants Clinical Trial Teams Can Trust: Q&A with E.K. Koh, Suvoda
2
What Needs to Happen Beyond the Clinical Trial Modernization Act
3
Walmart and Care Access Plan Three More Clinical Trial Centers in Michigan, Nevada, and Texas
4
Closing the Medical Writing Capacity Gap: Why Training Beats Technology
5